Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study

Plasma ADAMTS-13 protein is not associated with portal hypertension or hemodynamic changes in patients with cirrhosis

(2016) Signe Wiese et al.   DIGESTIVE AND LIVER DISEASE

Thrombophilic genetic factors PAI-1 4G-4G and MTHFR 677TT as risk factors of alcohol, cryptogenic liver cirrhosis and portal vein thrombosis, in a Caucasian population

(2015) Mario D'Amico et al.   GENE

Liver sinusoidal endothelial cells in hepatic fibrosis

(2015) Laurie D. DeLeve   HEPATOLOGY

Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count

(2015) S. Lancellotti et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Syndromes of Thrombotic Microangiopathy

(2014) James N. George et al.   NEW ENGLAND JOURNAL OF MEDICINE

Performance of two new automated assays for measuring von Willebrand activity: HemosIL AcuStar and Innovance

(2014) Emmanuel de Maistre et al.   THROMBOSIS AND HAEMOSTASIS

A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen

(2013) F. Stufano et al.   HAEMOPHILIA

An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: Implications for hemostasis and clinical outcome

(2013) Greg C. G. Hugenholtz et al.   HEPATOLOGY

Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis

(2012) Monika Ferlitsch et al.   HEPATOLOGY

ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score

(2012) Hiroaki Takaya et al.   HEPATOLOGY RESEARCH

Phenotypic Expression of ADAMTS13 in Glomerular Endothelial Cells

(2011) Ramesh Tati et al.   PLoS One

Portal Vein Thrombosis

(2010) Sameer Parikh et al.   AMERICAN JOURNAL OF MEDICINE

The Balance between von-Willebrand Factor and its Cleaving Protease ADAMTS13: Biomarker in Systemic Inflammation and Development of Organ Failure?

(2010) R. Claus et al.   CURRENT MOLECULAR MEDICINE

Familial risks of unusual forms of venous thrombosis: a nationwide epidemiological study in Sweden

(2010) B. Zöller et al.   JOURNAL OF INTERNAL MEDICINE

Association between reduced ADAMTS13 and diabetic nephropathy

(2010) Shotaro Taniguchi et al.   THROMBOSIS RESEARCH

Portal vein thrombosis: Insight into physiopathology, diagnosis, and treatment

(2010) Francesca R Ponziani   WORLD JOURNAL OF GASTROENTEROLOGY

Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage

(2009) N. A. Turner et al.   BLOOD

Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stress

(2009) Stefano Lancellotti et al.   FREE RADICAL BIOLOGY AND MEDICINE

Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development

(2009) Maria Assunta Zocco et al.   JOURNAL OF HEPATOLOGY

Mechanistic Studies on ADAMTS13 Catalysis

(2008) Enrico Di Stasio et al.   BIOPHYSICAL JOURNAL

Coagulation and fibrosis in chronic liver disease

(2008) V Calvaruso et al.   GUT

Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells

(2008) W. J. CAO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS